Thermo Fisher Scientific, Inc. (TMO)
673.82
-2.72
(-0.40%)
USD |
NYSE |
Oct 23, 16:00
673.70
-0.12
(-0.02%)
After-Hours: 20:00
Thermo Fisher Scientific Shareholders Equity (Quarterly) : 54.77B for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 54.77B |
| June 30, 2026 | 52.68B |
| March 31, 2026 | 51.93B |
| December 31, 2025 | 53.41B |
| September 30, 2025 | 51.02B |
| June 30, 2025 | 50.51B |
| March 31, 2025 | 49.39B |
| December 31, 2024 | 49.58B |
| September 30, 2024 | 48.99B |
| June 30, 2024 | 47.43B |
| March 31, 2024 | 45.52B |
| December 31, 2023 | 46.74B |
| September 30, 2023 | 45.33B |
| June 30, 2023 | 43.75B |
| March 31, 2023 | 42.26B |
| December 31, 2022 | 43.98B |
| September 30, 2022 | 43.55B |
| June 30, 2022 | 42.29B |
| March 31, 2022 | 40.96B |
| December 31, 2021 | 40.79B |
| September 30, 2021 | 38.71B |
| June 30, 2021 | 36.85B |
| March 31, 2021 | 35.06B |
| December 31, 2020 | 34.51B |
| September 30, 2020 | 31.82B |
| Date | Value |
|---|---|
| June 30, 2020 | 29.88B |
| March 31, 2020 | 28.56B |
| December 31, 2019 | 29.68B |
| September 30, 2019 | 29.36B |
| June 30, 2019 | 28.73B |
| March 31, 2019 | 27.69B |
| December 31, 2018 | 27.59B |
| September 30, 2018 | 26.89B |
| June 30, 2018 | 26.44B |
| March 31, 2018 | 26.12B |
| December 31, 2017 | 25.41B |
| September 30, 2017 | 24.70B |
| June 30, 2017 | 22.39B |
| March 31, 2017 | 21.80B |
| December 31, 2016 | 21.54B |
| September 30, 2016 | 21.66B |
| June 30, 2016 | 21.26B |
| March 31, 2016 | 20.92B |
| December 31, 2015 | 21.35B |
| September 30, 2015 | 20.85B |
| June 30, 2015 | 20.68B |
| March 31, 2015 | 19.91B |
| December 31, 2014 | 20.55B |
| September 30, 2014 | 20.51B |
| June 30, 2014 | 20.66B |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 7.363B |
| Danaher Corp. | 53.62B |
| Illumina, Inc. | 2.838B |
| Bio-Rad Laboratories, Inc. | 7.174B |
| Revvity, Inc. | 7.229B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 114.23B |
| Total Liabilities (Quarterly) | 59.34B |
| Debt to Equity Ratio | 0.7554 |
| Current Ratio | 1.808 |
| Net Debt Paydown Yield | -0.49% |